OXOLIFE is developing the first drug that will treat female infertility by improving the endometrium to enhance the embryo implantation in the uterus.
In the largest study that has ever been performed in Spain, 350 women from three different countries who cannot have children will be recruited.
The team has managed to raise five million euros of funding.
Many thanks to Laia Bruguera Trabal and Juanma Ramos for the article and the pictures, respectively, both capture the essence of Oxolife!
Link: https://www.elpuntavui.cat/societat/article/5-societat/2012145-aproximacio-inedita.html